What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Internal medicine, Transplantation, Immunology, Surgery and Gastroenterology.
Internal medicine and Oncology are commonly linked in his work.
His research investigates the link between Oncology and topics such as Lymphoma that cross with problems in Chimeric antigen receptor and Minimal residual disease.
His Transplantation research is multidisciplinary, incorporating elements of Hematology and Transplantation Conditioning.
His study in Immunology is interdisciplinary in nature, drawing from both Stem cell and Cell biology.
His study looks at the intersection of Gastroenterology and topics like Immunotherapy with Adoptive cell transfer.
His most cited work include:
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1962 citations)
- The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. (720 citations)
- Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression (547 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Transplantation, Oncology, Immunology and Surgery.
His Gastroenterology research extends to the thematically linked field of Internal medicine.
The Transplantation study combines topics in areas such as Regimen, Stem cell, Cumulative incidence and Fludarabine.
His Oncology research includes themes of Retrospective cohort study, Chemotherapy and Multiple myeloma.
His studies deal with areas such as Haematopoiesis and Cancer research as well as Immunology.
His Hematopoietic stem cell transplantation study incorporates themes from Survival rate and Transplantation Conditioning.
He most often published in these fields:
- Internal medicine (62.08%)
- Transplantation (50.24%)
- Oncology (30.26%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (62.08%)
- Transplantation (50.24%)
- Oncology (30.26%)
In recent papers he was focusing on the following fields of study:
Arnon Nagler mostly deals with Internal medicine, Transplantation, Oncology, Acute leukemia and Hematopoietic stem cell transplantation.
The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways.
His Transplantation research focuses on Incidence and how it connects with Multivariate analysis.
His research integrates issues of Refractory, Fludarabine, Multiple myeloma and Busulfan in his study of Oncology.
His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Survival rate, Human leukocyte antigen and Univariate analysis.
His Graft-versus-host disease research incorporates themes from Anti-thymocyte globulin and Immunology.
Between 2017 and 2021, his most popular works were:
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (99 citations)
- Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial (84 citations)
- Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. (81 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Arnon Nagler focuses on Internal medicine, Transplantation, Oncology, Hematopoietic stem cell transplantation and Acute leukemia.
His Internal medicine study frequently intersects with other fields, such as Gastroenterology.
His work carried out in the field of Transplantation brings together such families of science as Hematology, Retrospective cohort study, Total body irradiation, Stem cell and Disease.
His biological study spans a wide range of topics, including Young adult, Regimen, Marrow transplantation, Cell therapy and Fludarabine.
Arnon Nagler interconnects Survival rate, Transplantation Conditioning, Cumulative incidence and Intensive care medicine in the investigation of issues within Hematopoietic stem cell transplantation.
As a part of the same scientific study, Arnon Nagler usually deals with the Acute leukemia, concentrating on Busulfan and frequently concerns with ThioTEPA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
